Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for ANIP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 0.505M
March 31, 2026 17.55M
December 31, 2025 0.573M
September 30, 2025 -8.746M
June 30, 2025 -0.691M
March 31, 2025 7.469M
December 31, 2024 -1.382M
September 30, 2024 -0.512M
June 30, 2024 0.295M
March 31, 2024 6.07M
December 31, 2023 -1.738M
September 30, 2023 -4.911M
June 30, 2023 -81.31M
March 31, 2023 3.392M
December 31, 2022 -0.649M
September 30, 2022 -0.245M
June 30, 2022 0.28M
March 31, 2022 1.115M
December 31, 2021 -96.32M
September 30, 2021 0.073M
June 30, 2021 0.132M
March 31, 2021 0.348M
December 31, 2020 -0.169M
September 30, 2020 0.00
June 30, 2020 0.867M
Date Value
March 31, 2020 0.207M
December 31, 2019 -0.886M
September 30, 2019 -0.133M
June 30, 2019 -1.58M
March 31, 2019 -2.108M
December 31, 2018 -0.161M
September 30, 2018 -0.206M
June 30, 2018 -0.691M
March 31, 2018 -1.261M
December 31, 2017 -0.162M
September 30, 2017 -0.06M
June 30, 2017 0.153M
March 31, 2017 -0.025M
December 31, 2016 -0.208M
September 30, 2016 -0.858M
June 30, 2016 -0.238M
March 31, 2016 2.356M
December 31, 2015 -0.048M
September 30, 2015 -0.527M
June 30, 2015 -0.122M
March 31, 2015 -0.009M
December 31, 2014 15.01M
September 30, 2014 -0.034M
June 30, 2014 -46.68M
March 31, 2014 -0.923M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 149.30M
Liquidia Corp. -1.443M
Elanco Animal Health, Inc. 0.00
Harmony Biosciences Holdings, Inc. -5.517M
Corcept Therapeutics, Inc. -9.42M